The Neurofibromatosis Therapeutic Acceleration Program (NTAP) was established to accelerate the development of effective treatments for plexiform neurofibromas.

NTAP supports efforts that bridge the gap between early research discoveries and the clinic, ensuring people with plexiform neurofibromas can benefit from research advances as quickly as possible.

**NEW** Patient Reported Outcome Development RFA
  Due June 14, 2013